Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-02

Clinical Trial Update: Pilot Study Repetitive Transcranial Magnetic Stimulation (rTMS) in Cannabis Craving [Phase 1]

View source ↗

Summary

This document notes the withdrawal of a Phase 1 pilot trial investigating repetitive transcranial magnetic stimulation (rTMS) for cannabis craving.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • repetitive transcranial magnetic stimulation (rTMS)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Cannabis Use | Phase 1 | Status: WITHDRAWN